A bill to amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · Jun 8, 2026

View full text on Congress.gov ↗